Oxytetracycline

• Tablets 250mg (£1.21 = 28 tablets)

Indications

• Acne

Doxycycline

• Capsules 50mg (£1.56 = 28 capsules), 100mg (£1.15 = 8 capsules)
• Dispersible tablets sugar free 100mg (£4.91 = 8 dispersible tablets)
• Efracea modified-release capsules 40mg (£15.98 = 28 capsules)

Indications

• Acute sinusitis
• Community acquired pneumonia
• Chronic Pelvic Pain Syndrome
• Bites (animal and human) - with metronidazole
• Infected eczema (penicillin allergy)
• Acute cough, bronchitis
  • Adults aged 18 years and over - (first line)
  • Children and young people 12 years and over - (second line)
• Acute exacerbation of bronchiectasis (non-cystic fibrosis) - (first line)
• Acute exacerbations of COPD - (first line)
• Chlamydia trachomatis - (first line)
• Pelvic inflammatory disease
  • plus ceftriaxone IM and metronidazole - (first line) or
  • plus metronidazole (oral regime only)
• Lyme disease - (first line)
• Falciparum malaria - (specialist use)

Notes

1. Doxycycline 40mg (Efracea) is included for the treatment of rosacea
2. Dispersible tablets are considerably more expensive than capsules and should be reserved for use only in individuals who are unable to swallow capsules

Lymecycline

• Capsules 408mg (£4.09 = 28 capsules)

Indications

• Acne

Demeclocycline hydrochloride

• Capsules 150mg (£238.41 = 28 capsules)

Notes

1. Demeclocycline is not used for the treatment of infection, but is used in the management of inappropriate secretion of antidiuretic hormone.

Tigecycline

• Powder for solution for infusion vial 50mg

Minocycline

Following national guidance from NHS England, minocycline is not recommended for use for the treatment of acne due to an increased risk of adverse effects such as drug induced lupus, skin pigmentation and hepatitis. Click here for more information. Prescribers should not initiate minocycline for acne for any new patient.